TearLab Corporation (NASDAQ: TEAR) and Cooper Companies, Inc. (The) (NYSE:COO) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.
Valuation and Earnings
This table compares TearLab Corporation and Cooper Companies, Inc. (The)’s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| TearLab Corporation | $27.95 million | 0.45 | -$9.93 million | ($3.33) | -0.65 |
| Cooper Companies, Inc. (The) | $2.05 billion | 5.80 | $635.85 million | $6.67 | 36.47 |
Cooper Companies, Inc. (The) has higher revenue and earnings than TearLab Corporation. TearLab Corporation is trading at a lower price-to-earnings ratio than Cooper Companies, Inc. (The), indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
29.6% of TearLab Corporation shares are owned by institutional investors. Comparatively, 98.1% of Cooper Companies, Inc. (The) shares are owned by institutional investors. 11.6% of TearLab Corporation shares are owned by company insiders. Comparatively, 1.6% of Cooper Companies, Inc. (The) shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent ratings and price targets for TearLab Corporation and Cooper Companies, Inc. (The), as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TearLab Corporation | 0 | 0 | 4 | 0 | 3.00 |
| Cooper Companies, Inc. (The) | 0 | 3 | 6 | 0 | 2.67 |
TearLab Corporation presently has a consensus price target of $5.75, suggesting a potential upside of 164.98%. Cooper Companies, Inc. (The) has a consensus price target of $238.00, suggesting a potential downside of 2.17%. Given TearLab Corporation’s stronger consensus rating and higher probable upside, equities analysts plainly believe TearLab Corporation is more favorable than Cooper Companies, Inc. (The).
Risk and Volatility
TearLab Corporation has a beta of 2.68, suggesting that its share price is 168% more volatile than the S&P 500. Comparatively, Cooper Companies, Inc. (The) has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.
Profitability
This table compares TearLab Corporation and Cooper Companies, Inc. (The)’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TearLab Corporation | -61.14% | N/A | -60.70% |
| Cooper Companies, Inc. (The) | 16.02% | 15.88% | 9.62% |
Dividends
Cooper Companies, Inc. (The) pays an annual dividend of $0.06 per share and has a dividend yield of 0.0%. TearLab Corporation does not pay a dividend. Cooper Companies, Inc. (The) pays out 0.9% of its earnings in the form of a dividend.
Summary
Cooper Companies, Inc. (The) beats TearLab Corporation on 10 of the 15 factors compared between the two stocks.
TearLab Corporation Company Profile
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor’s office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Cooper Companies, Inc. (The) Company Profile
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses. CooperVision services three primary regions: the Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific. CooperVision offers spherical, aspherical, toric, multifocal and toric multifocal lens products in various modalities. CooperVision’s products are primarily manufactured at its facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica and New York. CooperSurgical offers an array of products and services focused on advancing the health of families through a portfolio of products and services focusing on women’s health, fertility and diagnostics.
Receive News & Ratings for TearLab Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TearLab Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
